Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-19 Purchase | 2024-11-20 4:20 pm | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 666,666 | $2.25 | $1,499,999 | 710,030 (Direct) | View |
| 2024-08-02 Purchase | 2024-08-05 3:57 pm | Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner | 373,569 | $1.2655 | $472,757 | 14,250,000 (Indirect) | View |
| 2024-07-30 Purchase | 2024-07-31 4:10 pm | Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner | 273,730 | $1.3115 | $359,010 | 13,876,421 (Indirect) | View |
| 2024-07-18 Purchase | 2024-07-22 4:03 pm | Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner | 154,722 | $1.3043 | $201,808 | 13,602,691 (Indirect) | View |
| 2024-07-02 Purchase | 2024-07-05 2:46 pm | Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner | 352,397 | $1.1518 | $405,894 | 13,447,969 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-05 Option Award | 2025-06-09 4:20 pm | N/A 2035-06-04 | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 53,930 | $0 | 502,345 (Direct) | View |
| 2025-06-06 Exercise | 2025-06-09 4:20 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 4,793 | $0 | 502,345 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:20 pm | N/A 2035-06-04 | Aclaris Therapeutics Inc. | ACRS | MILANO VINCENT Director | 53,930 | $0 | 71,246 (Direct) | View |
| 2025-06-06 Exercise | 2025-06-09 4:20 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | MILANO VINCENT Director | 4,793 | $0 | 71,246 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:20 pm | N/A 2035-06-04 | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 53,930 | $0 | 768,753 (Direct) | View |
| 2025-06-06 Exercise | 2025-06-09 4:20 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 4,793 | $0 | 768,753 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:20 pm | N/A 2035-06-04 | Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director | 53,930 | $0 | 87,455 (Direct) | View |
| 2025-06-06 Exercise | 2025-06-09 4:20 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director | 4,793 | $0 | 87,455 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:20 pm | N/A 2035-06-04 | Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director | 53,930 | $0 | 75,684 (Direct) | View |
| 2025-06-06 Exercise | 2025-06-09 4:20 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director | 4,793 | $0 | 75,684 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:20 pm | N/A 2035-06-04 | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 53,930 | $0 | 111,886 (Direct) | View |
| 2025-06-06 Exercise | 2025-06-09 4:20 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 4,793 | $0 | 111,886 (Direct) | View |
| 2025-05-01 Option Award | 2025-05-05 4:32 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Hall Jesse Wayne Chief Medical Officer | 655,500 | $0 | 655,500 (Direct) | View |
| 2025-05-01 Exercise | 2025-05-05 4:20 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 9,467 | $0 | 1,479,824 (Direct) | View |
| 2025-05-01 Tax Withholding | 2025-05-05 4:20 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 2,975 | $1.38 | 1,479,824 (Direct) | View |
| 2025-04-01 Tax Withholding | 2025-04-03 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 3,042 | $1.48 | 1,482,799 (Direct) | View |
| 2025-04-01 Exercise | 2025-04-03 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 9,467 | $0 | 1,482,799 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 727 | $1.99 | 94,983 (Direct) | View |
| 2025-03-01 Exercise | 2025-03-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 3,475 | $0 | 94,983 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 3,277 | $1.99 | 1,485,841 (Direct) | View |
| 2025-03-01 Exercise | 2025-03-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 9,466 | $0 | 1,485,841 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 27,258 | $1.99 | 276,780 (Direct) | View |
| 2025-03-01 Exercise | 2025-03-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 60,925 | $0 | 276,780 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Davis Hugh M. President and COO | 336,300 | $0 | 336,300 (Direct) | View |
| 2025-02-01 Tax Withholding | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM CEO | 3,559 | $2.48 | 2,631,818 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM CEO | 1,142,700 | $0 | 2,631,818 (Direct) | View |
| 2025-02-01 Exercise | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM CEO | 9,467 | $0 | 2,631,818 (Direct) | View |
| 2025-02-01 Tax Withholding | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 11,317 | $2.48 | 668,838 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 377,400 | $0 | 668,838 (Direct) | View |
| 2025-02-01 Exercise | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 22,250 | $0 | 668,838 (Direct) | View |
| 2025-02-01 Tax Withholding | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 5,816 | $2.48 | 530,410 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 396,300 | $0 | 530,410 (Direct) | View |
| 2025-02-01 Exercise | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 14,750 | $0 | 530,410 (Direct) | View |
| 2025-02-01 Tax Withholding | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 15,447 | $2.48 | 549,606 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 375,800 | $0 | 549,606 (Direct) | View |
| 2025-02-01 Exercise | 2025-02-04 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 33,500 | $0 | 549,606 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 6:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 52,667 | $0 | 382,959 (Direct) | View |
| 2024-12-31 Tax Withholding | 2025-01-03 6:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 41,851 | $0 | 382,959 (Direct) | View |
| 2024-12-31 Exercise | 2025-01-03 6:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 91,130 | $0 | 382,959 (Direct) | View |
| 2024-12-31 Tax Withholding | 2025-01-03 6:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 38,221 | $2.48 | 236,476 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 6:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 40,000 | $0 | 236,476 (Direct) | View |
| 2024-12-31 Exercise | 2025-01-03 6:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 94,450 | $0 | 236,476 (Direct) | View |
| 2024-12-31 Tax Withholding | 2025-01-03 6:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 40,664 | $2.48 | 250,853 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 6:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 55,000 | $0 | 250,853 (Direct) | View |
| 2024-12-31 Exercise | 2025-01-03 6:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 91,900 | $0 | 250,853 (Direct) | View |
| 2025-01-01 Tax Withholding | 2025-01-03 6:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM CEO | 17,436 | $2.48 | 1,640,194 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 6:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM CEO | 88,333 | $0 | 1,640,194 (Direct) | View |
| 2025-01-01 Exercise | 2025-01-03 6:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM CEO | 38,616 | $0 | 1,640,194 (Direct) | View |
| 2024-12-10 Gift | 2024-12-12 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 15,000 | $0 | 171,976 (Direct) | View |
| 2024-12-04 Tax Withholding | 2024-12-06 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM CEO | 68,343 | $3.76 | 1,433,630 (Direct) | View |
| 2024-12-04 Exercise | 2024-12-06 4:15 pm | N/A 2024-12-07 | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM CEO | 118,840 | $0 | 1,433,630 (Direct) | View |
| 2024-12-04 Exercise | 2024-12-06 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM CEO | 118,840 | $1.52 | 1,433,630 (Direct) | View |
| 2024-12-02 Option Award | 2024-12-03 5:42 pm | N/A 2034-12-01 | Aclaris Therapeutics Inc. | ACRS | Davis Hugh M. President and COO | 482,000 | $0 | 482,000 (Direct) | View |
| 2024-12-01 Exercise | 2024-12-03 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM CEO | 9,466 | $0 | 1,430,467 (Direct) | View |
| 2024-12-01 Tax Withholding | 2024-12-03 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM CEO | 2,721 | $4.07 | 1,430,467 (Direct) | View |
Ownership | 2024-11-25 11:03 am | 2024-11-18 N/A | Aclaris Therapeutics Inc. | ACRS | Biosion Inc. 10% Owner | 0 | $0 | 11,281,985 (Direct) | View |
| 2024-11-01 Tax Withholding | 2024-11-05 4:20 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 2,721 | $2.09 | 1,433,188 (Direct) | View |
| 2024-11-01 Exercise | 2024-11-05 4:20 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 9,467 | $0 | 1,433,188 (Direct) | View |
| 2024-10-01 Tax Withholding | 2024-10-03 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 2,722 | $1.18 | 1,435,909 (Direct) | View |
| 2024-10-01 Exercise | 2024-10-03 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 9,467 | $0 | 1,435,909 (Direct) | View |
| 2024-09-01 Tax Withholding | 2024-09-04 7:52 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 286 | $1.18 | 24,697 (Direct) | View |
| 2024-09-01 Exercise | 2024-09-04 7:52 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 1,000 | $0 | 24,697 (Direct) | View |
| 2024-09-01 Tax Withholding | 2024-09-04 5:08 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 2,722 | $1.18 | 1,438,631 (Direct) | View |
| 2024-09-01 Exercise | 2024-09-04 5:08 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 9,466 | $0 | 1,438,631 (Direct) | View |
| 2024-08-09 Exercise | 2024-08-13 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 43,548 | $0.72 | 1,356,153 (Direct) | View |
| 2024-08-09 Exercise | 2024-08-13 4:15 pm | N/A 2024-08-12 | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 43,548 | $0 | 1,356,153 (Direct) | View |
| 2024-08-01 Tax Withholding | 2024-08-05 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 2,722 | $1.32 | 1,397,805 (Direct) | View |
| 2024-08-01 Exercise | 2024-08-05 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 9,467 | $0 | 1,397,805 (Direct) | View |
| 2024-07-01 Tax Withholding | 2024-07-03 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 2,722 | $1.15 | 1,400,527 (Direct) | View |
| 2024-07-01 Exercise | 2024-07-03 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 9,467 | $0 | 1,400,527 (Direct) | View |